Mid-Del Therapeutic Ctr., Inc. v. Commissioner

2000 T.C. Memo. 383, 80 T.C.M. 894, 2000 Tax Ct. Memo LEXIS 452
United States Tax Court·Decided December 19, 2000·No. No. 9060-97; No. 9270-97·Unpublished

Opinion

MID-DEL THERAPEUTIC CENTER, INC., Petitioner v. COMMISSIONER OF INTERNAL REVENUE, Respondent D. RICHARD ISHMAEL, M.D., PC, Petitioner v. COMMISSIONER OF INTERNAL REVENUE, Respondent
Mid-Del Therapeutic Ctr., Inc. v. Commissioner
No. 9060-97; No. 9270-97
United States Tax Court
T.C. Memo 2000-383; 2000 Tax Ct. Memo LEXIS 452; 80 T.C.M. (CCH) 894; T.C.M. (RIA) 54159;
December 19, 2000, Filed

*452 Appropriate orders and decisions will be entered.

Bruce A. Moates and LeRoy D. Boyer, for petitioners.
Elizabeth Downs, for respondent.
Marvel, L. Paige

MARVEL

MEMORANDUM OPINION

MARVEL, JUDGE: These cases are before the Court on petitioners' motion for award of litigation and administrative costs 1 filed pursuant to section 7430 and Rule 231. 2 Petitioners seek to recover litigation costs of $ 44,456 incurred in contesting respondent's deficiency determinations in docket No. 9060-97 for the taxable year ended April 30, 1995, and in docket No. 9270-97 for the taxable year 1995.

The issues for decision are whether*453 respondent's position at trial was substantially justified and, if not, whether the attorney's fees and other costs that petitioners seek to recover are reasonable in amount. Neither petitioners nor respondent requested an evidentiary hearing, and the Court concludes that such a hearing is not necessary for the proper disposition of petitioners' motion. See Rule 232(a)(2).

BACKGROUND

Petitioner Mid-Del Therapeutic Center, Inc. (Mid-Del), and petitioner D. Richard Ishmael, M.D., PC (PC), are Oklahoma corporations, each of which operates an oncology clinic in the Oklahoma City metropolitan area. On the dates the petitions in these consolidated cases were filed, Mid-Del's principal place of business was in Midwest City, Oklahoma, and PC's principal place of business was in Oklahoma City, Oklahoma. Dr. D. Richard Ishmael, an oncologist, owns 100 percent of the stock of both Mid-Del and PC. PC is Dr. Ishmael's personal service corporation, and Mid-Del is a subchapter C corporation owned and managed by Dr. Ishmael.

During the relevant periods, petitioners operated medical clinics that purchased and used chemotherapy drugs (drugs) to treat patients with cancer and other illnesses. PC maintained*454 an onsite pharmacy where the drugs purchased by both PC and Mid-Del were stored and where a pharmacist employed by PC mixed and prepared chemotherapy treatments for both clinics. Petitioners used approximately 85 different drugs to treat patients.

With the exception of Mid-Del's Federal income tax return for the taxable year 1993, both Mid-Del and PC used the cash method of accounting (cash method) for income tax purposes and consistently reported the drugs used in patient treatments as supplies and not as inventory. Mid-Del's 1993 return, which originally was filed using the accrual method of accounting (accrual method), was amended to report income and expenses on the cash method after a revenue agent determined on audit that Mid-Del was required to use the cash method. It was a customary and accepted practice in the health care industry for health care practitioners to use the cash method.

By notices of deficiency dated April 23, 1997, respondent determined deficiencies of $ 140,025 and $ 211,979 in Mid-Del's and PC's Federal income taxes, respectively. The crux of the deficiencies was respondent's determination, made pursuant to section 446(b), that petitioners must use an accrual*455 method to compute their taxable income.

By separate petitions, petitioners commenced their cases in this Court, and the cases were consolidated for trial. Respondent argued at trial that the drugs used to treat patients were merchandise, the purchase and sale of which were income-producing factors in petitioners' businesses, and that petitioners, therefore, were required by section 1.471-1, Income Tax Regs., to use the accrual method to compute their taxable income. Petitioners asserted that the drugs were supplies used in the course of treating patients and that section 1.471-1, Income Tax Regs., was inapplicable.

Section 446(b) vests the Commissioner with broad discretion to determine whether a particular method of accounting clearly reflects income. See Knight-Ridder Newspapers, Inc. v. United States, 743 F.2d 781, 788 (11th Cir. 1984); Ansley-Sheppard-Burgess Co. v. Commissioner, 104 T.C. 367, 370 (1995). In reviewing the Commissioner's determination that a taxpayer's method of accounting does not clearly reflect income, the function of the Court is to decide whether the Commissioner abused his discretion

Free access — add to your briefcase to read the full text and ask questions with AI

Mid-Del Therapeutic Ctr., Inc. v. Commissioner, 2000 T.C. Memo. 383, 80 T.C.M. 894, 2000 Tax Ct. Memo LEXIS 452 (tax 2000).

2000 T.C. Memo. 383 (Mid-Del Therapeutic Ctr., Inc. v. Commissioner) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Thor Power Tool Co. v. Commissioner
439 U.S. 522 (Supreme Court, 1979)
Commissioner v. Asphalt Products Co.
482 U.S. 117 (Supreme Court, 1987)
Pierce v. Underwood
487 U.S. 552 (Supreme Court, 1988)
Rca Corporation v. United States
664 F.2d 881 (Second Circuit, 1981)
Knight-Ridder Newspapers, Inc. v. United States
743 F.2d 781 (Eleventh Circuit, 1984)
Eldon D. And Kathy A. Anthony v. United States
987 F.2d 670 (Tenth Circuit, 1993)
Estate of Wall v. Commissioner
102 T.C. No. 13 (U.S. Tax Court, 1994)
Ansley-Sheppard-Burgess Co. v. Commissioner
104 T.C. No. 17 (U.S. Tax Court, 1995)
MAGGIE MGMT. CO. v. COMMISSIONER OF INTERNAL REVENUE
108 T.C. No. 21 (U.S. Tax Court, 1997)
Ezo Products Co. v. Commissioner
37 T.C. 385 (U.S. Tax Court, 1961)
Cole v. Commissioner
64 T.C. 1091 (U.S. Tax Court, 1975)
Don Casey Co. v. Commissioner
87 T.C. No. 54 (U.S. Tax Court, 1986)
Stieha v. Commissioner
89 T.C. No. 55 (U.S. Tax Court, 1987)